DR. ROMAN IVAN CZUBATYJ (M.D.) – Non-Pharmacy Dispensing Site, NPI 1972797892
Non-Pharmacy Dispensing Site
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
216 RHEUMATOLOGY in MI
Provider Addresses for DR. ROMAN IVAN CZUBATYJ (M.D.)
1701 SOUTH BOULEVARD EAST
SUITE 140
ROCHESTER HILLS, MI 483071804
Phone: (248) 853-0803
Fax: (248) 852-5859
Type: Mailing
1701 SOUTH BLVD E STE 110
ROCHESTER HILLS, MI 483076118
Phone: (248) 853-0803
Fax: (248) 852-5859
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 607 Open Payments records for all available years, with a total value of $340,365.
Total Amount is formed as General ($340,365) + Research ($0) + Ownership ($0) = $340,365.
Last reported payment date: 2024-12-18 • Largest payer in this snapshot: Amgen Inc. ($141,451).
Total Amount
$340,365
General + Research + Ownership
Payments
607
Total payment records
General Amount
$340,365
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-18
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Amgen Inc. | $141,451 |
| Horizon Therapeutics plc | $105,876 |
| ABBVIE INC. | $47,551 |
| Janssen Biotech, Inc. | $39,852 |
| Janssen Scientific Affairs, LLC | $3,604 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2011-06-29
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20110629000529 | I | Rheumatology | MI | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 28,800 | 36 | $0 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 292 | 58 | $0 |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 169 | 125 | $0 |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | 146 | 146 | $0 |
| 96415 | Administration of chemotherapy into vein, each additional hour | 89 | 14 | $0 |
Insurance plans in this area (ZIP 48307)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| RHEUMATOLOGY | MI | 20610 | Aspiration and/or injection of large joint or joint capsule | 76 | 32 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| R H E U M A T O L O G Y | MI | |
| Rheumatology, Internal Medicine | MI | |
| R H E U M A T O L O G Y | MI | |
| Physician Assistant | MI | |
| Physician Assistant | MI | |
| Physician Assistant | MI |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.